New evidence links paclitaxel-containing devices with mortality risk

But the PAD study shows no dose-response relationship and fails to identify a mechanism, researchers say

A second meta-analysis has linked paclitaxel-containing devices used in peripheral artery disease (PAD) with increased long-term mortality risk.